Surveillance of Measles and Rubella in Bagmati Province, Nepal: An Analysis of Facilitators and Challenges Through Mixed Methods Research - Scorecard - DentalSpire

Surveillance of Measles and Rubella in Bagmati Province, Nepal: An Analysis of Facilitators and Challenges Through Mixed Methods Research

  • By

  • Bipsana Shrestha

  • Surakshya Kunwar

  • Alina Upreti

  • Kshitij Karki

  • Paras Pangeni

  • Poonam Subedi

  • Leela Khanal

  • Rajeev Shrestha

  • Dipesh Tamrakar

  • Bhim Singh Tinkari

  • Shyam Raj Upreti

  • February 24, 2026

  • 0 min

Share

Clinical Scorecard: Surveillance of Measles and Rubella in Bagmati Province, Nepal: An Analysis of Facilitators and Challenges Through Mixed Methods Research

At a Glance

CategoryDetail
ConditionMeasles and Rubella
Key MechanismsHigh vaccination coverage and effective surveillance systems are essential for elimination.
Target PopulationChildren under 15 years of age in Bagmati Province, Nepal.
Care SettingHealth facilities including government hospitals, private hospitals, Primary Health Care Centers, and Health Posts.

Key Highlights

  • Measles remains a leading cause of childhood morbidity and mortality worldwide.
  • In 2023, Nepal recorded 962 confirmed measles cases and 14 outbreaks.
  • High vaccination coverage in Nepal: 97% for MR1 and 95% for MR2.
  • Challenges include delayed specimen transport and inadequate outbreak response.
  • Revised target for measles elimination in Nepal set for 2026.

Guideline-Based Recommendations

Diagnosis

  • Utilize laboratory confirmation through ELISA testing for suspected cases.

Management

  • Implement timely outbreak-response supplementary immunization activities (SIAs).

Monitoring & Follow-up

  • Achieve a target of 80% for reporting IgM results within 4 days.

Risks

  • Immunity gaps and the impact of COVID-19 on vaccination programs.

Patient & Prescribing Data

Children in Bagmati Province who are unvaccinated or under-vaccinated.

Simplified diagnostic tools could improve measles testing timeliness.

Clinical Best Practices

  • Ensure high vaccine coverage and effective surveillance systems.
  • Transport samples from hard-to-reach areas within 72 hours under a reverse cold chain.
  • Conduct regular training for health personnel on surveillance and outbreak response.

References

Original Source(s)

Related Content